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Introduction. The aim of this study was to examine the incidence and risk factors of catheterization-related CI in the contemporary
era, using diffusion-weighted magnetic resonance imaging. Methods. We retrospectively analyzed consecutive 84 patients who
underwentMRI (magnetic resonance imaging) after 2.81±2.4 days (mean±SD) of catheterization via aortic arch.We categorized the
patients by the presence or absence of acute CI determined by diffusion-weighted MRI and analyzed the incidence and predictors.
Results. Of 84 patients that underwent MRI after catheterization, acute CI was determined in 27 (32.1%) patients. In univariate
analysis, dyslipidemia, age, coronary artery disease, antiplatelet agents, number of catheters used, urgent settings, and interventional
procedures were significantly different. Multivariate analysis revealed dyslipidemia (odds ratio [OR], 4.46; 95% confidence interval
[CI], 1.41–16.03; 𝑝 = 0.01), higher age (OR, 1.09; 95% CI, 1.007–1.19; 𝑝 = 0.03), and the number of catheters used (OR, 2.21; 95%
CI, 1.21–4.36; 𝑝 = 0.01) as independent predictors of the incidence of catheterization-related acute CI. Conclusions. Dyslipidemia,
higher age, and number of catheters used were independent predictors for acute CI after catheterization. These findings imply that
managing dyslipidemia and comprehensive planning to minimize the numbers of catheters are important.
1. Introduction
Catheterization is an established procedure for evaluation
and intervention in cardiac and peripheral artery diseases.
Catheterization-related acute stroke is a rare (reported inci-
dence, 0.44%) but potentially devastating complication asso-
ciated with high comorbidity and mortality [1–3]. Acute
stroke associated with catheterization is classified into two
major categories: symptomatic cerebral infarction (CI) and
hemorrhagic stroke; respective rates are reported as 0.22%
and 0.21% in retrospective study, and the causative mecha-
nisms are potentially different [1]. Catheterization-related CI
is caused mainly by dislodgement of atherosclerotic debris
from the aorta during catheterization [4]. Furthermore, air
embolism [5], thrombus formation in or on the surface of
the catheter, changes of devices in the catheters, and hemody-
namic compromise [6] are capable of causing acute cerebral
injury during catheterization.
On the other hand, unperceived acute CI after catheter-
ization could be detected at an unexpectedly high rate
on diffusion-weighted (DW) magnetic resonance imaging
(MRI), as described in 4.9–34.7% of patients [7–15]. Combi-
nation of DW imaging and apparent coefficient (ADC) maps
on MRI is commonly accepted technique for assessment of
acute CI [16, 17]. CI is reported to be a cause of decline in cog-
nitive function, even if there were no symptoms [18]. While
temporal trends in catheterization have changed, such as
increased adoption of the radial approach and complex per-
cutaneous coronary intervention [2, 19, 20], recently, patients
undergoing catheterization have been older and at greater
risk of atherosclerosis [20]. Here, we present an analysis
of risk factors and current incidence for catheterization-
related CI detected using DW MRI, as well as the features
of MRI findings. In this retrospective study, we investigated
patients considered at high risk, including those suspected of
acute stroke, those who underwent catheterization prior to
Hindawi Publishing Corporation
BioMed Research International
Volume 2016, Article ID 6052125, 7 pages
http://dx.doi.org/10.1155/2016/6052125
2 BioMed Research International
Table 1: The reasons for MRI in the study subjects.
𝑛 = 84
Candidates for coronary artery bypass grafting, % 31 (26)
Candidates for valvular surgery, % 15.8 (13)
Prior syncope, % 11.9 (10)
Assessments for symptoms, % 11.9 (10)
Candidates for pacemaker implantation, % 6 (5)
Candidates for aortic repair, % 6 (5)
Candidates for peripheral vascular surgery, % 3.6 (3)
Others, % 14.3 (12)
cardiovascular surgery, and those who underwent urgent
catheterization.
2. Methods
2.1. Study Population. A total of 1237 patients underwent
catheterization via the aortic arch at the Cardiovascular
Center, Kitano Hospital, between June 2010 and June 2012.
Of these, we retrospectively identified 84 patients who under-
went MRI after the catheterization at all, excluding those
who underwent MRI more than 14 days after the procedure.
Because the decrease in apparent diffusion coefficient (ADC)
signals caused by acute CI was presumed to have returned
to the baseline after several weeks [21], we used retrieval
software and retrospectively reviewed medical records for
each patient. The mean time period after the catheterization
at which MRI was performed was 2.81 ± 2.4 days (mean ±
SD). The reasons for MRI were shown in Table 1. Among
all the patients, 26 patients (31%) were candidates for coro-
nary artery bypass grafting, 15 patients (15.8%) for valvular
surgery, 10 patients (11.9%) for assessments of symptoms,
and 8 patients (9.6%) for peripheral artery or aortic surgery.
Diagnostic and interventional procedures were performed
according to current guidelines [22–25]. The research proto-
col was approved by the Institutional Review Board of Kitano
Hospital according to the ethical guidelines of the 1975Decla-
ration of Helsinki. Since this is a retrospective study, the con-
sent was not obtained and patient records/information was
anonymized and deidentified prior to analysis.
2.2. Study Protocol. A medical history was documented in
each patient prior to the catheterization procedure, which
was performed by cardiologists. The following informa-
tion was retrieved for each patient: DW MRI findings,
catheterization procedure, left ventricular ejection fraction
(LVEF) on echocardiography, and preprocedural medica-
tion. Baseline clinical characteristics include diabetes, smok-
ing, dyslipidemia, family history of coronary artery disease
(CAD), presence of CAD, prior stroke,myocardial infarction,
peripheral vascular disease (PVD), renal impairment, and
persistent atrial fibrillation (AF). Hypertension was defined
as systolic blood pressure ≧140mmHg, diastolic blood pres-
sure ≧90mmHg, or the use of antihypertensive drugs.
Dyslipidemia was defined as either low-density lipoprotein
cholesterol (LDL) ≧140mg/dL or the use of statin. Renal
impairment was defined as creatinine ≧1.5mg/dL. CAD was
defined as a diameter stenosis of 70% or more in at least one
major epicardial artery by coronary angiography at the time
of the study or earlier. CAD included myocardial infarction.
Severe aortic stenosis was defined as either an aortic valve
area ≦1.0 cm2, mean pressure gradient ≧40mmHg, or aortic
jet velocity ≧4.0m/s according to the guideline [23].
2.3. Catheterization Procedures. Catheterization was under-
taken by senior cardiologists in the upper limbs or femoral
approach. Appropriate unfractionated heparin was adminis-
tered, usually 3000 units for diagnostic procedures and an
additional 5000 units for intervention. Contrast mediumwas
injected with an automatic injection device (ACIST CVi®;
Dvx Inc., Tokyo, Japan).
2.4. Cerebral MRI and Neurological Assessments. An MRI
of the brain (1.5-Tesla Achieva Nova Dual, Philips Medical
Systems, Netherlands) was performed after the catheteriza-
tion. The imaging protocol included DW single-shot spin
echo-planar [repetition time (TR), 2700 to 4300ms; echo
time (TE), 55 to 84ms; slice thickness, 5mm; matrix, 256 ×
256; diffusion gradient, 𝑏 values of 0 and 1000 s/mm2], fluid-
attenuated inversion recovery [FLAIR; TR/TE/inversion time
(TI), 8000 to 11000/120 to 125/2400 to 2800ms], and T2-
weighted turbo spin echo (TR/TE, 3700 to 4600/80 to 100ms)
sequences. For each DW sequence, the apparent diffusion
coefficient (ADC)map was obtained to exclude false-positive
results by a T2 shine-through effect. Acute embolic lesions
were defined as focal diffusion abnormalities (bright hyperin-
tense lesions) confirmed on the ADC map. All MRI findings
were analyzed by senior radiologists aware of the clinical sta-
tus and identity of the patients. The localization and number
of the lesions were analyzed.We diagnosed acute CI from the
combinations of DW imaging and ADC map findings.
2.5. Statistical Analysis. Baseline and procedural characteris-
tics of the study population are described as mean ± standard
deviation (SD) for quantitative variables and number or per-
centage for categorical variables. Differences between the CI
and non-CI groups were tested by univariate analysis (Pear-
son’s chi-squared test and Welch’s 𝑡-test, as appropriate). Val-
ues of 𝑝 < 0.05 were considered statistically significant. All
variables with a 𝑝 value <0.05 in the univariate analysis were
entered in a nominal logistic regression model by using the
forced-entry method because of the small number of patients
despite the risk of existing confounding factors. The lack-of-
fit test was used to check the adjustment of the model. Nom-
inal logistic regression analysis was used in the multivariate
analysis, and odds ratios (ORs) and 95% confidence intervals
(95% CIs) were calculated for independent predictors of CI.
All statistics were calculated using JMP v10.0.0 (SAS Institute
Inc., Chicago, IL, USA).
3. Results
3.1. Patient and Procedural Characteristics. Among a total of
1237 catheterization procedures, 84 patients (56 men and 28
women; mean age, 71.6 ± 8.7 years) who underwent MRI





84 patients obtained MRI ≦ 14 days
1237 catheterization
procedures
Figure 1: Flowchart of the study population. MRI: magnetic
resonance imaging; CI: cerebral infarction.
within 14 days after catheterization (mean duration, 2.81 ±
2.4 days) were included in the study. A flowchart of the
study population is shown in Figure 1. DW MRI revealed
acute CI in 27 of 84 patients (32.1%). No patient revealed a
hemorrhagic lesion. Among 1237 catheterization procedures,
3 patients and 1 patientwere clinically diagnosed as stroke and
TIA, respectively. We categorized the study subjects into two
groups according to the presence or absence of acute CI and
compared the patient and procedural characteristics between
them (Tables 2 and 3).
Among patient characteristics, patients who exhibited CI
on DW MRI were significantly older and had significantly
higher rates of dyslipidemia, CAD, and current usage of
antiplatelet drugs than patients without CI in univariate anal-
ysis. Other factors including hypertension, diabetes mellitus,
smoking, renal impairment, decreased LVEF (<40%), severe
aortic stenosis, prior myocardial infarction, prior stroke,
history of atrial fibrillation, and peripheral vascular disease
were not different between the groups (Table 2).
Among procedural characteristics, the number of cathe-
ters used (2.85 ± 1.1 versus 2.12 ± 0.9, 𝑝 = 0.004) was
significantly greater in the infarction group in univariate
analysis. Patients with CI more often underwent procedures
in urgent settings (22.2% versus 7%, 𝑝 = 0.05) and for
interventional purposes (25.9% versus 8.8%, 𝑝 = 0.04).There
were no significant differences in procedural factors, includ-
ing catheter size, total contrast volume, left ventriculography
(LVG), aortography (AoG), and approach sites (Table 3).
Inmultivariate analysis, age (OR, 1.09; 95%CI, 1.007–1.19;
𝑝 = 0.03), dyslipidemia (OR, 4.46; 95% CI, 1.41–16.03; 𝑝 =
0.01), and number of catheters used (OR, 2.21; 95% CI, 1.21–
4.36; 𝑝 = 0.01) were independently associated with acute CI
after the procedures (Table 4).
3.2. Features of MRI Findings. Features of MRI findings are
shown in Table 5. Patients with CI revealed multiple lesions
(3.89 ± 4.1). More lesions were observed in bilateral (52%)
and anterior plus posterior territories (37%). There was no
association among the characteristics of procedures, patients,
and lesions.
4. Discussion
In this retrospective analysis of catheterization patients in
a single institution, we investigated the incidence and risk
factors of CI following catheterization. Of note, dyslipidemia,
higher age, and number of catheters used were revealed
as independent predictors for the incidence of acute CI.
Previous studies indicated that impaired cognitive function
was associated with cerebral microinfarction as detected with
transcranial Doppler ultrasound imaging or DWI [18, 26].
Cerebral microinfarctions correlate with impaired cognitive
function and previous studies. To help reduce the occurrence
of CI in catheterization patients, these factors need to be
considered.
Among baseline and procedural characteristics tested
within the present study, dyslipidemia, age, and number
of catheters used were identified as independent predictors
of CI. Previous studies using DW MRI have reported that
possible risk factors are related to atherosclerotic burden
and mechanical stress, including hypertension [12], history
of vasculopathy [7], number of catheters used [7], fluo-
roscopy time [7, 9, 10], amount of contrast medium [7],
performing internal mammary artery angiography [13], and
retrograde passage of the aortic valve [8]. Previous studies
using DW MRI found no association between lipid profile
and catheterization-related CI [7–14]. Despite the fact that
the development of atherosclerotic CAD is associated with
LDL, TG, and HDL levels [27], as well as the total level of
cholesterol [27, 28], to the best of our knowledge, lipid profile
has not been found to have a significant effect on the inci-
dence of CI after catheterization [1, 6, 12]. Unlike other studies
that defined dyslipidemia as high total cholesterol (TC) alone
[8, 9, 11–15, 29] and as either high TC or statin usage [10],
the present study defined dyslipidemia as high LDL level
(≥140mg/dL) or the usage of statin. The result of the
multivariate analysis showed dyslipidemia as a predictor of
catheterization-related CI (OR, 4.46; 95% CI, 1.41–16.03; 𝑝 =
0.01; Table 4). Meanwhile either high LDL or the usage
of statin alone was not significantly different. The possible
reason is that patients already using statin were still at higher
risk of atherosclerosis. It has been reported that statins were
effective for vascular events in patients with aortic plaques
[30]. How long the statin needs to be used and what level of
LDL should be achieved to reduce catheterization-related CI
warrant assessment in future study. Dislodgement of aortic
plaque material is assumed to be a source of embolism
in patients undergoing catheterization [4], and it has been
reported that dyslipidemia is associated with greater aortic
plaque thickness in first-ever ischemic stroke patients [31].
Karalis et al. have shown that atherosclerotic aortic debris
detected by transesophageal echocardiography is a risk fac-
tor for cerebral and peripheral embolism during invasive
procedures [32]. Taken together, these results indicate that
dyslipidemia associated with increased atheroma burden is a
potential risk factor for catheterization-related CI.
Higher age emerged as an independent predictor in the
present study. Consistent with our findings, Hoffman et al.
have reported that higher age is an independent predictor for
PCI-related stroke and TIA [3]. Higher age is a major risk
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Table 2: Baseline characteristics of the study subjects.
All CI No CI
𝑝
𝑛 = 84 𝑛 = 27 𝑛 = 57
Age, yr 71.6 ± 8.7 74.1 ± 6.6 70.4 ± 9.4 0.04∗
Male, % 61.9 66.7 59.7 0.53
Hypertension, % 73.8 77.8 71.9 0.57
Dyslipidemia (LDL ≧ 140mg/dL/statin user), % 45.2 63 36.8 0.04∗
LDL ≧ 140 mg/dL, % 10.7 14.8 8.8 0.46
Diabetes, % 42.9 55.6 36.8 0.11
Smoking, % 59.5 63 57.9 0.66
Family history, % 10.7 11.1 10.5 0.94
Prior stroke, % 14.3 18.5 12.3 0.45
Prior MI, % 26.2 29.6 24.6 0.62
MI within 7 days prior, % 6.0 11.1 3.5 0.17
EF < 40, % 13.1 22.2 8.8 0.09
PVD, % 28.6 40.7 22.8 0.09
CAD, % 60.7 77.8 52.6 0.03∗
Cre > 1.5mg/dL, % 14.3 14.8 14.4 0.92
Severe aortic stenosis, % 11.9 3.7 15.8 0.11
AF, % 10.7 14.8 8.8 0.40
Preprocedural medication
Statin, % 38.1 51.9 31.6 0.09
ACE-I/ARB, % 47.6 51.9 45.6 0.59
Beta blocker, % 29.8 37 26.3 0.32
CCB, % 51.2 55.6 49.1 0.58
Antiplatelet, % 53.6 74 43.9 0.01∗
Anticoagulation, % 13.1 18.5 10.5 0.31
∗Included in multivariate analysis.
LDL: low-density lipoprotein; MI: myocardial infarction; PVD: peripheral vascular disease; CAD: coronary artery disease; AF: atrial fibrillation; ACE-I:
angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker.
Table 3: Procedural characteristics.
All CI No CI
𝑝
𝑛 = 84 𝑛 = 27 𝑛 = 57
No. of catheters used 2.35 ± 1.0 2.85 ± 1.1 2.12 ± 0.87 0.004∗
Catheter size, Fr 4.31 ± 0.66 4.44 ± 0.80 4.25 ± 0.58 0.25
Contrast volume, mL 122.8 ± 55 128 ± 55 120 ± 55 0.57
Fluoroscopy time, min 18.9 ± 13.1 22.7 ± 14 17.1 ± 12.3 0.08
LV angiogram, % 45.2 48.2 43.9 0.71
Ao angiogram, % 13.1 11.1 14.0 0.71
Urgent, % 11.9 22.2 7.0 0.05∗
IABP, % 1.2 3.7 0 0.14
Purpose of procedure
Diagnostic, % 85.7 74.1 91.2 0.04∗
Interventional, % 14.3 25.9 8.8 0.04∗
Approach site
Upper limbs, % 81.0 81.5 80.7 0.93
Femoral, % 19.0 18.5 19.3 0.93
∗Included in multivariate analysis.
LVG: left ventriculography; AoG: aortography; IABP: intra-aortic balloon pumping.
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Table 4: Multivariate analysis to determine factors associated with acute CI after catheterization.
OR 95% CI 𝑝
Age (increase per 1 year) 1.09 1.007–1.19 0.03∗
Dyslipidemia (high LDL/statin user) 4.46 1.41–16.03 0.01∗
CAD 1.64 0.42–6.67 0.47
Antiplatelet use 1.69 0.46–6.33 0.42
Number of catheters used (increase per 1 catheter) 2.21 1.21–4.36 0.01∗
Urgent 3.43 0.61–22.84 0.16
Interventional 1.27 0.24–6.4 0.77
Lack-of-fit test 0.43 (Prob > 𝜒2)
∗Independent predictor for CI.
CAD: coronary artery disease.
Table 5: Features of MRI findings.
Patients with CI
𝑛 = 27 (%)
Lesions per patient 3.89 ± 4.1
Patients with a single lesion 9 (33)
Patients with multiple lesions 18 (67)
Lesion location, patients
Right hemisphere 6 (22)
Left 7 (26)
Bilateral lesions 14 (52)
Anterior circulation territory 10 (37)
Posterior 7 (26)
Anterior and posterior 10 (37)
factor for atherosclerotic CAD and development of aortic
plaque burden [33–35]. Therefore, higher age is possibly
associated with risk of catheter-induced embolization.
Number of catheters used was also an independent
predictor for CI in the present study. MRI disclosed that
bilateral lesions were present in 52% of the CI group, even
though a large proportion of the procedures were performed
via either the right or left upper limbs in the present study.
Multiple catheter usage might increase the chance of dislodg-
ing aortic plaque material, resulting in embolization [7]. It
appears likely that the risk of air embolism and dislocation of
thrombus from catheters increases with catheter exchanges.
Previous studies using DW MRI have identified fluoroscopy
time and number of vessels probed as risk factors for CI.
These procedural factors could increase the risk of formation
of small blood clots and scraping aortic plaques [5, 7, 9, 36].
Continuous heparin flushing might be effective for preven-
tion of intracatheter clot formation. Our findings support
that scraping plaques from the ascending aorta and intro-
ducing air bubbles with contrast medium are major factors
in catheterization-related CI; therefore, careful planning is
needed to reduce rates of catheterization-related CI.
LVG did not influence the incidence of CI in the present
study. Because it has been assumed that passing through a
calcified aortic valve could serve as a source of embolism
[8], patients with severely calcified aortic valves or apparent
severe aortic stenosis on echocardiography did not undergo
LVG in our study.
In the present study, CI was detected in 27 of 84 patients
(32.1%) undergoing catheterization. This rate of CI is rela-
tively high compared with previous studies using DW MRI
(4.9% to 34.7%) [7–15]. Lund et al. [10] described an incidence
of CI of 11.9% in a prospective evaluation with DW MRI,
with lower mean age (59.3 ± 9.3 versus 71.6 ± 8.7) and fewer
diabetic patients (14.9% versus 42.9%). Meanwhile, Murai
et al. [15] reported that acute CI was observed in 34.7%
of patients with acute coronary syndrome after primary
coronary intervention. The present study also included the
patients undergoing urgent catheterization (11.9%). In addi-
tion, overall stroke/TIA was observed in 4 of 1237 patients
(0.32%) in the present study, the rate of which was almost
equivalent to the previous studies [1–3].Therefore, differences
in the demographics of the patients could explain the rela-
tively high incidence of CI in our study.
There are several limitations in the present study. First,
the small sample size (𝑛 = 84), single-center, and ret-
rospective analysis might limit the statistical power and
validity of the conclusion. Selection bias also exists in the
present study, because MRI was not performed for series of
catheterization procedures. Otherwise, since the incidence
of catheterization-related CI remains high, 4.9% to 34.7% in
other reports [7–15] and 32.1% in our report, this analysis pro-
vides insights into reducing the risk of catheterization-related
CI. Second, patients did not undergo preproceduralMRI.The
patients were determined to have acute CI according to high
DWI and lowADC signals. Since it is reported that decreased
ADC returns to the baseline after 1–4 weeks [21], subacute CI
that developed spontaneously just before the catheterization
was not excluded. However, only 3 patients in a total of 580
patients in previous studies displayed acute CI onDWMRI in
preproceduralMRI [7–9, 11, 12, 29]. Because of lowprevalence
of acute CI observed in preprocedural MRI, several studies
are performed only after the catheterization like our study
[15, 37]. Therefore, a positive finding on a postprocedural
MRI strongly indicates acute CI after catheterization.
5. Conclusion
Dyslipidemia, age, and number of catheters used appear to
be risk factors for catheterization-related CI detected with
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DWMRI.These findings imply that intervention against dys-
lipidemia and comprehensive planning to minimize catheter
exchanges are important.
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